Yamasa Of Japan In Deal With Merck To Develop New Type Of HIV Drug
This article was originally published in PharmAsia News
Executive Summary
Japan's Yamasa has signed an agreement with Merck to develop an HIV/AIDS drug that laboratory studies suggested would be effective against highly resistant HIV strains.